Literature DB >> 34617356

Do naloxone access laws affect perceived risk of heroin use? Evidence from national US data.

Brian C Kelly1, Mike Vuolo2.   

Abstract

BACKGROUND AND AIMS: Whether expanded access to naloxone reduces perceptions of risk about opioid use has been subject to debate. Our aim was to assess how implementation of naloxone access laws shapes perceived risk of heroin use.
DESIGN: Using data from the restricted-access National Survey on Drug Use and Health, Prescription Drug Abuse Policy System and the US Census, we applied two-way fixed-effects models to determine whether naloxone access laws decreased perceived risk of any heroin use or regular heroin use. We used Bayes factors (BFs) to confirm evidence for null findings.
SETTING: United States. PARTICIPANTS: A total of 884 800 respondents aged 12 and older from 2004 to 2016. MEASUREMENTS: A binary indicator of whether a state implemented naloxone access laws was regressed on respondent-perceived risk of (1) any heroin use and (2) regular heroin use. Ratings of perceived risk were assessed on a scale of 1 (none) to 4 (great risk).
FINDINGS: In all instances, the BFs support evidence for the null hypothesis. Across models with three distinct specifications of naloxone access laws, we found no evidence of decreased risk perceptions, as confirmed by BFs ranging from 0.009 to 0.057. Across models of specific vulnerable subgroups, such as people who use opioids (BFs = 0.039-0.225) or young people (BFs = 0.009-0.158), we found no evidence of decreased risk perceptions. Across diverse subpopulations by gender (BFs = 0.011-0.083), socio-economic status (BFs = 0.015-0.168) or race/ethnicity (BFs = 0.016-0.094), we found no evidence of decreased risk perceptions.
CONCLUSIONS: There appears to be no empirical evidence that implementation of naloxone access laws has adversely affected perceptions of risk of heroin in the broader US population or within vulnerable subgroups or diverse subpopulations.
© 2021 Society for the Study of Addiction.

Entities:  

Keywords:  Harm reduction; heroin; naloxone; opioids; perceived risk; policy

Mesh:

Substances:

Year:  2021        PMID: 34617356      PMCID: PMC8844056          DOI: 10.1111/add.15682

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  34 in total

1.  Trends in crime and the introduction of a needle exchange program.

Authors:  M A Marx; B Crape; R S Brookmeyer; B Junge; C Latkin; D Vlahov; S A Strathdee
Journal:  Am J Public Health       Date:  2000-12       Impact factor: 9.308

2.  Using Bayesian analysis for hypothesis testing in addiction science.

Authors:  Robert West
Journal:  Addiction       Date:  2015-10-21       Impact factor: 6.526

3.  Smokers' unrealistic optimism about their risk.

Authors:  N D Weinstein; S E Marcus; R P Moser
Journal:  Tob Control       Date:  2005-02       Impact factor: 7.552

4.  Conceptions of risk in the lives of club drug-using youth.

Authors:  Brian C Kelly
Journal:  Subst Use Misuse       Date:  2005       Impact factor: 2.164

5.  Heroin overdose: the case for take-home naloxone.

Authors:  J Strang; S Darke; W Hall; M Farrell; R Ali
Journal:  BMJ       Date:  1996-06-08

6.  State naloxone access laws are associated with an increase in the number of naloxone prescriptions dispensed in retail pharmacies.

Authors:  Jing Xu; Corey S Davis; Marisa Cruz; Peter Lurie
Journal:  Drug Alcohol Depend       Date:  2018-05-29       Impact factor: 4.492

7.  Educational Disparities in Adult Health: U.S. States as Institutional Actors on the Association.

Authors:  Jennifer Karas Montez; Mark D Hayward; Anna Zajacova
Journal:  Socius       Date:  2019-03-11

8.  Distribution of naloxone for overdose prevention to chronic pain patients.

Authors:  Marion A Coe; Sharon L Walsh
Journal:  Prev Med       Date:  2015-05-27       Impact factor: 4.018

Review 9.  Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States.

Authors:  Rosanna Smart; Bryce Pardo; Corey S Davis
Journal:  Addiction       Date:  2020-07-08       Impact factor: 6.526

10.  Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths.

Authors:  Mahesh K B Parmar; John Strang; Louise Choo; Angela M Meade; Sheila M Bird
Journal:  Addiction       Date:  2016-12-13       Impact factor: 6.526

View more
  1 in total

1.  Beliefs and misperceptions about naloxone and overdose among U.S. laypersons: a cross-sectional study.

Authors:  Jon Agley; Yunyu Xiao; Lori Eldridge; Beth Meyerson; Lilian Golzarri-Arroyo
Journal:  BMC Public Health       Date:  2022-05-10       Impact factor: 4.135

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.